アジア太平洋地域のウイルスベクター精製市場 – 業界動向と2028年までの予測

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

アジア太平洋地域のウイルスベクター精製市場 – 業界動向と2028年までの予測

  • Healthcare
  • Published Report
  • May 2021
  • Asia-Pacific
  • 350 ページ
  • テーブル数: 227
  • 図の数: 42

>アジア太平洋地域のウイルスベクター精製市場、製品とサービス別(製品とサービス)、タイプ(レトロウイルスベクター、ワクチンウイルス、アデノウイルスベクター、アデノ随伴ウイルスベクター、レンチウイルス、その他)、ワークフロー(上流処理と下流処理)、精製技術(密度勾配超遠心分離、限外濾過、沈殿、2相抽出システム、クロマトグラフィー)、運用規模(前臨床/臨床および商業)、送達方法(生体内および生体外)、疾患の適応症(がん、遺伝性疾患、感染症、獣医疾患、その他)、用途(アンチセンスおよびRNAi、遺伝子治療、細胞治療、ワクチン学)、エンドユーザー(バイオテクノロジー企業、製薬会社、受託研究機関、受託開発製造組織(CDMO)、学術/研究機関)、国(日本、中国、オーストラリア、インド、韓国、シンガポール、インドネシア、タイ、マレーシア、フィリピン、その他のアジア太平洋地域) の業界動向と2028年までの予測

アジア太平洋地域のウイルスベクター精製市場市場分析と洞察: アジア太平洋地域のウイルスベクター精製市場

ウイルスベクター精製市場は、2021年から2028年の予測期間に市場成長を遂げると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に15.3%のCAGRで成長し、2028年までに2億6,622万米ドルに達すると分析しています。ウイルスベクターの需要の高まりは、ウイルスベクター精製市場の原動力となっています。

分子生物学者は、遺伝物質を細胞に送達するためにウイルスベクターを頻繁に使用します。この手順は、生体内(生体内)または細胞培養内(試験管内)で実行できます。ウイルスは、感染した細胞内にゲノムを効率的に輸送するための特殊な分子メカニズムを開発しました。形質導入は、ベクターによる遺伝子またはその他の遺伝物質の送達であり、感染した細胞は形質導入されたと呼ばれます。

COVID-19の出現とウイルスワクチンの需要により、ウイルスベクター精製市場が拡大しています。スケーラビリティの欠如は、ウイルスベクター精製市場の制約となっています。感染症の増加は、ウイルスベクター精製市場にとってチャンスとなっています。熟練した人材の不足は、ウイルスベクター精製市場の課題となっています。

ウイルスベクター精製市場レポートでは、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から見た機会の分析が提供されます。分析とウイルスベクター精製市場のシナリオを理解するには、アナリスト概要について Data Bridge Market Research にお問い合わせください。当社のチームが、希望する目標を達成するための収益影響ソリューションの作成をお手伝いします。

アジア太平洋地域のウイルスベクター精製市場ウイルスベクター精製市場の範囲と市場規模

ウイルスベクター精製市場は、製品とサービス、タイプ、ワークフロー、精製技術、運用規模、提供方法、疾患の兆候、アプリケーション、およびエンドユーザーに基づいて、9 つの主要なセグメントに分類されます。セグメント間の成長は、ニッチな成長分野と市場にアプローチするための戦略を分析し、コアアプリケーション領域とターゲット市場の違いを決定するのに役立ちます。

  • 製品とサービスに基づいて、ウイルスベクター精製市場は製品とサービスに分類されます。2021年には、ベクター精製のためのさまざまな革新的なソリューションが利用可能になったため、製品セグメントがウイルスベクター精製市場を支配すると予想されます。
  • タイプに基づいて、ウイルスベクター精製市場は、レトロウイルスベクター、ワクチンウイルス、アデノウイルスベクター、アデノ随伴ウイルスベクター、レンチウイルス、その他に分類されます。 2021年には、AAVの感染性の範囲が広いため、アデノ随伴ウイルスベクターセグメントがウイルスベクター精製市場を支配すると予想されます。
  • ワークフローに基づいて、ウイルスベクター精製市場は上流処理と下流処理に分割されます。2021 年には、上流処理セグメントがウイルスベクター精製市場を支配すると予想されます。これは、このプロセスを使用して生成されたウイルスベクターが、トランスフェクション後の短い時間枠で細胞から収穫できるためです。
  • 精製技術に基づいて、ウイルスベクター精製市場は、密度勾配超遠心分離、限外濾過、沈殿、二相抽出システム、クロマトグラフィーに分類されます。2021年には、クロマトグラフィーセグメントがワクチンや遺伝子治療ベクターの精製に広く使用されているため、ウイルスベクター精製市場を支配すると予想されます。
  • 事業規模に基づいて、ウイルスベクター精製市場は前臨床/臨床と商業に分類されます。2021年には、主要な医療機関による研究開発活動への投資の増加により、前臨床/臨床セグメントがウイルスベクター精製市場を支配すると予想されます。
  • 送達方法に基づいて、ウイルスベクター精製市場は、in vivo と ex vivo に分割されます。2021 年には、その高い可用性とプロセスの信頼性により、in vivo セグメントがウイルスベクター精製市場を支配すると予想されます。
  • 病気の兆候に基づいて、ウイルスベクター精製市場は、がん、遺伝性疾患、感染症、獣医疾患、その他に分類されます。 2021年には、遺伝性疾患の発生率と有病率の上昇により、遺伝性疾患セグメントがウイルスベクター精製市場を支配すると予想されます。
  • 用途に基づいて、ウイルスベクター精製市場は、アンチセンスおよびRNAi、遺伝子治療、細胞治療、ワクチン学に分類されます。2021年には、医療分野での幅広い用途により、遺伝子治療セグメントがウイルスベクター精製市場を支配すると予想されます。
  • エンドユーザーに基づいて、ウイルスベクター精製市場は、バイオテクノロジー企業、製薬会社、契約研究機関、契約開発製造組織(CDMO)、学術/研究機関に分類されます。2021年には、さまざまなヘルスケア組織や政府機関による研究努力を奨励するためのイニシアチブ活動の増加により、学術/研究機関セグメントがウイルスベクター精製市場を支配すると予想されます。

アジア太平洋地域のウイルスベクター精製市場の国別分析

アジア太平洋地域のウイルスベクター精製市場が分析され、市場規模の情報が、上記の国、製品とサービス、タイプ、ワークフロー、精製技術、運用規模、提供方法、疾患の兆候、用途、およびエンドユーザー別に提供されます。

アジア太平洋地域のウイルスベクター精製市場レポートで取り上げられている国は、日本、中国、オーストラリア、インド、韓国、シンガポール、インドネシア、タイ、マレーシア、フィリピン、およびその他のアジア太平洋地域です。

アジア太平洋地域は、人口の急増と医療費の増加により、ウイルスベクター精製の需要が急速に高まっているため、予測期間中に最も速いCAGRで成長すると予想されています。日本は、治療に高度なウイルスベクター精製製品を利用するアジア太平洋地域の主要国の一つであるため、アジア太平洋地域のウイルスベクター精製市場で優位に立つと予想されています。    

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、アジア太平洋ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。  

メーカーによる戦略的取り組みが、ウイルスベクター精製市場のプレーヤーに新たな機会を生み出している 

ウイルスベクター精製市場では、各国の成長に関する詳細な市場分析も提供しています。さらに、アジア太平洋地域のウイルスベクター精製市場プレーヤー間のウイルスベクター精製販売、パートナーシップ、買収、流通契約の成長に関する詳細なデータも提供しています。データは、2011年から2019年までの履歴期間について利用可能です。  

競争環境とウイルスベクター精製市場シェア分析

ウイルスベクター精製市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と広さ、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータポイントは、アジア太平洋のウイルスベクター精製市場に関連する会社の焦点にのみ関連しています。

アジア太平洋地域のウイルスベクター精製市場レポートで取り上げられている主な企業は、Applied Biological Materials Inc.、Creative Biolabs、Bio-Rad Laboratories, Inc.、Sirion-Biotech GmbH、Merck KGaA、Batavia Biosciences BV、Agilent Technologies, Inc.、Addgene、Takara Bio Inc.、Thermo Fisher Scientific Inc.、uniQure NV、BioVision Inc.、Cytiva (Danaher の子会社)、BIA Separations などの国内企業です。DBMR のアナリストは、競争上の強みを理解し、各競合他社の競合分析を個別に提供します。

世界中の企業によって多くの契約や協定も開始されており、これもウイルスベクター精製市場の発展を加速させています。  

例えば、  

  • 2021年1月、サーモフィッシャーサイエンティフィック社は、ベルギーのノヴセップ社のウイルスベクター製造事業の買収を完了し、同社の市場のさらなる多様化に貢献すると発表しました。

市場プレーヤーによるコラボレーション、合弁事業、その他の戦略により、ウイルスベクター精製市場における企業の印象が強化され、組織にとっても売上成長を向上させるメリットがもたらされます。  

 

 


SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 MARKET OVERVIEW

4.1 DRIVERS

4.1.1 RISING DEMAND FOR VIRAL VECTORS

4.1.2 AVAILABILITY OF DIVERSE RANGE OF INNOVATIVE SOLUTIONS FOR VECTOR PURIFICATION

4.1.3 EMERGENCE OF COVID-19 AND DEMAND FOR VACCINE DEVELOPMENT

4.1.4 BENEFITS OF VIRAL VECTORS FOR GENE THERAPY

4.1.5 GROWING USAGE OF AAV VECTORS FOR DELIVERY OF SIRNA IN MAMMALIAN CELLS

4.2 RESTRAINTS

4.2.1 LACK OF SCALABILITY

4.2.2 LIMITATIONS OF DOWNSTREAM PURIFICATION

4.3 OPPORTUNITIES

4.3.1 GROWING CANCER BURDEN WORLDWIDE

4.3.2 RISING NUMBER OF INFECTIOUS DISEASES

4.3.3 GROWING GERIATRIC POPULATION

4.3.4 RISING HEALTH CONSCIOUSNESS AND INCREASING SPENDING ON HEALTHCARE

4.4 CHALLENGES

4.4.1 BIOLOGICAL CHALLENGES

4.4.2 SHORTAGE OF SKILLED PERSONNEL

5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: REGULATIONS

1 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES

1.1 OVERVIEW

1.2 PRODUCTS

1.2.1 RESIN

1.2.2 KIT

1.2.3 REAGENT

1.2.4 PREPACKED COLUMN

1.2.5 CASSETTE

1.2.6 CAPSULE

1.2.7 FILTER PLATE

1.3 SERVICES

2 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE

2.1 OVERVIEW

2.2 CHROMATOGRAPHY

2.2.1 AFFINITY CHROMATOGRAPHY

2.2.2 ION-EXCHANGE CHROMATOGRAPHY

2.2.3 SIZE-EXCLUSION CHROMATOGRAPHY

2.2.4 HYDROPHILIC INTERACTION CHROMATOGRAPHY

2.3 DENSITY-GRADIENT ULTRACENTRIFUGATION

2.4 ULTRAFILTRATION

2.5 PRECIPITATION

2.6 TWO-PHASE EXTRACTION SYSTEMS

3 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY TYPE

3.1 OVERVIEW

3.2 ADENO-ASSOCIATED VIRAL VECTORS

3.3 ADENOVIRAL VECTORS

3.3.1 MASTADENOVIRUS

3.3.2 AVIADENOVIRUS

3.3.3 SIADENOVIRUS

3.3.4 ATADENOVIRUS

3.3.5 ICHTADENOVIRUS

3.4 LENTIVIRUS

3.5 RETROVIRAL VECTORS

3.5.1 REPLICATION DEFECTIVE

3.5.2 REPLICATION-COMPETENT

3.6 VACCINE VIRUS

3.7 OTHER

4 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW

4.1 OVERVIEW

4.2 UPSTREAM PROCESSING

4.3 DOWNSTREAM PROCESSING

5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION

5.1 OVERVIEW

5.2 PRECLINICAL / CLINICAL

5.3 COMMERCIAL

6 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY MODE

6.1 OVERVIEW

6.2 IN VIVO

6.3 EX VIVO

7 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION

7.1 OVERVIEW

7.2 GENETIC DISORDERS

7.2.1 THALASSEMIA

7.2.2 CYSTIC FIBROSIS

7.2.3 TAY-SACHS DISEASE

7.2.4 SICKLE CELL ANEMIA

7.2.5 OTHERS

7.3 INFECTIOUS DISEASES

7.3.1 MEASLES VIRUS

7.3.2 VESICULAR STOMATITIS VIRUS

7.3.3 NOVEL ADENOVIRUSES

7.3.4 CYTOMEGALOVIRUS

7.3.5 OTHERS

7.4 VETERINARY DISEASE

7.5 CANCER

7.6 OTHER

8 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 GENE THERAPY

8.2.1 RECOMBINANT PROTEIN EXPRESSION

8.2.2 FUNCTIONAL ASSAYS

8.2.3 PROTEIN CHARACTERIZATION

8.2.4 IN VITRO TRANSCRIPTION

8.2.5 OTHERS

8.3 CELL THERAPY

8.4 VACCINOLOGY

8.5 ANTISENSE & RNAI

9 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY END USER

9.1 OVERVIEW

9.2 ACADEMIC/ RESEARCH INSTITUTES

9.3 PHARMACEUTICAL COMPANIES

9.4 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO)

9.5 BIOTECHNOLOGY COMPANIES

9.6 CONTRACT RESEARCH ORGANIZATIONS

10 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY GEOGRAPHY

10.1 ASIA-PACIFIC

10.1.1 JAPAN

10.1.2 SOUTH KOREA

10.1.3 AUSTRALIA

10.1.4 SINGAPORE

10.1.5 MALAYSIA

10.1.6 THAILAND

10.1.7 INDONESIA

10.1.8 PHILIPPINES

10.1.9 REST OF ASIA-PACIFIC

11 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12 COMPANY PROFILE

12.1 THERMO FISHER SCIENTIFC INC.

12.1.1 COMPANY SNAPSHOT

12.1.2 REVENUE ANALYSIS

12.1.3 COMPANY SHARE ANALYSIS

12.1.4 PRODUCT PORTFOLIO

12.1.5 RECENT DEVELOPMENTS

12.2 CYTIVA (A SUBSIDIARY OF DANAHER)

12.2.1 COMPANY SNAPSHOT

12.2.2 REVENUE ANALYSIS

12.2.3 COMPANY SHARE ANALYSIS

12.2.4 PRODUCT PORTFOLIO

12.2.5 RECENT DEVELOPMENT

12.3 MERCK KGAA

12.3.1 COMPANY SNAPSHOT

12.3.2 REVENUE ANALYSIS

12.3.3 COMPANY SHARE ANALYSIS

12.3.4 PRODUCT PORTFOLIO

12.3.5 RECENT DEVELOPMENT

12.4 AGILENT TECHNOLOGIES, INC.

12.4.1 COMPANY SNAPSHOT

12.4.2 REVENUE ANALYSIS

12.4.3 COMPANY SHARE ANALYSIS

12.4.4 PRODUCT PORTFOLIO

12.4.5 RECENT DEVELOPMENT

12.5 FUJIFILM DIOSYNTH BIOTECHNOLOGIES

12.5.1 COMPANY SNAPSHOT

12.5.2 PRODUCT PORTFOLIO

12.6 ADDGENE

12.6.1 COMPANY SNAPSHOT

12.6.2 PRODUCT PORTFOLIO

12.6.3 RECENT DEVELOPMENT

12.7 ALDEVRON

12.7.1 COMPANY SNAPSHOT

12.7.2 PRODUCT PORTFOLIO

12.7.3 RECENT DEVELOPMENTS

12.8 APPLIED BIOLOGICAL MATERIALS INC.

12.8.1 COMPANY SNAPSHOT

12.8.2 PRODUCT PORTFOLIO

12.8.3 RECENT DEVELOPMENT

12.9 BIA SEPARATIONS

12.9.1 COMPANY SNAPSHOT

12.9.2 PRODUCT PORTFOLIO

12.9.3 RECENT DEVELOPMENTS

12.1 BIO-RAD LABORATORIES, INC.

12.10.1 COMPANY SNAPSHOT

12.10.2 REVENUE ANALYSIS

12.10.3 PRODUCT PORTFOLIO

12.10.4 RECENT DEVELOPMENT

12.11 BIOVISION INC.

12.11.1 COMPANY SNAPSHOT

12.11.2 PRODUCT PORTFOLIO

12.11.3 RECENT DEVELOPMENT

12.12 BATAVIA BIOSCIENCES B.V.

12.12.1 COMPANY SNAPSHOT

12.12.2 PRODUCT PORTFOLIO

12.12.3 RECENT DEVELOPMENT

12.13 CREATIVE BIOGENE

12.13.1 COMPANY SNAPSHOT

12.13.2 PRODUCT PORTFOLIO

12.13.3 RECENT DEVELOPMENTS

12.14 CREATIVE BIOLABS

12.14.1 COMPANY SNAPSHOT

12.14.2 SERVICE PORTFOLIO

12.15 IDT BIOLOGIKA GMBH

12.15.1 COMPANY SNAPSHOT

12.15.2 PRODUCT PORTFOLIO

12.15.3 RECENT DEVELOPMENTS

12.16 PROBIOGEN AG

12.16.1 COMPANY SNAPSHOT

12.16.2 PRODUCT PORTFOLIO

12.16.3 RECENT DEVELOPMENTS

12.17 SIRION-BIOTECH GMBH

12.17.1 COMPANY SNAPSHOT

12.17.2 PRODUCT PORTFOLIO

12.17.3 RECENT DEVELOPMENTS

12.18 TAKARA BIO INC.

12.18.1 COMPANY SNAPSHOT

12.18.2 REVENUE ANALYSIS

12.18.3 PRODUCT PORTFOLIO

12.18.4 RECENT DEVELOPMENTS

12.19 UNIQURE N.V.

12.19.1 COMPANY SNAPSHOT

12.19.2 REVENUE ANALYSIS

12.19.3 PRODUCT PORTFOLIO

12.19.4 RECENT DEVELOPMENT

12.2 WAISMAN BIOMANUFACTURING

12.20.1 COMPANY SNAPSHOT

12.20.2 PRODUCT PORTFOLIO

12.20.3 RECENT DEVELOPMENTS

13 QUESTIONNAIRE

14 RELATED REPORTS

表のリスト

LIST OF TABLES

TABLE 1 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 2 ASIA-PACIFIC PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 ASIA-PACIFIC PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 4 ASIA-PACIFIC SERVICES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 6 ASIA-PACIFIC CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 ASIA-PACIFIC CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 8 ASIA-PACIFIC DENSITY-GRADIENT ULTRACENTRIFUGATION IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 ASIA-PACIFIC ULTRAFILTRATION IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 ASIA-PACIFIC PRECIPITATION IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 ASIA-PACIFIC TWO-PHASE EXTRACTION SYSTEMS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 13 ASIA-PACIFIC ADENO-ASSOCIATED VIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 ASIA-PACIFIC ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 ASIA-PACIFIC ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 16 ASIA-PACIFIC LENTIVIRUS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 ASIA-PACIFIC RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 ASIA-PACIFIC RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 19 ASIA-PACIFIC VACCINE VIRUS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 ASIA-PACIFIC OTHER IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 22 ASIA-PACIFIC UPSTREAM PROCESSING IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 ASIA-PACIFIC DOWNSTREAM PROCESSING IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)

TABLE 25 ASIA-PACIFIC PRECLINICAL / CLINICAL IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 ASIA-PACIFIC COMMERCIAL IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)

TABLE 28 ASIA-PACIFIC IN VIVO IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 ASIA-PACIFIC EX VIVO IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 ASIA-PACIFIC GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 33 ASIA-PACIFIC INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 ASIA-PACIFIC INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 35 ASIA-PACIFIC VETERINARY DISEASE IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 ASIA-PACIFIC CANCER IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 ASIA-PACIFIC OTHER IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 39 ASIA-PACIFIC GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 ASIA-PACIFIC GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 41 ASIA-PACIFIC CELL THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 ASIA-PACIFIC VACCINOLOGY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 43 ASIA-PACIFIC ANTISENSE & RNAI IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 45 ASIA-PACIFIC ACADEMIC/ RESEARCH INSTITUTES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 ASIA-PACIFIC PHARMACEUTICAL COMPANIES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 47 ASIA-PACIFIC CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 48 ASIA-PACIFIC BIOTECHNOLOGY COMPANIES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 49 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 50 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

TABLE 51 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 52 ASIA-PACIFIC PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 53 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 54 ASIA-PACIFIC CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 55 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 56 ASIA-PACIFIC RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 57 ASIA-PACIFIC ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 58 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 59 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)

TABLE 60 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 61 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 62 ASIA-PACIFIC GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 63 ASIA-PACIFIC INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 64 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 65 ASIA-PACIFIC GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 66 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 67 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 68 JAPAN PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 69 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 70 JAPAN CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 71 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 72 JAPAN RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 73 JAPAN ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 74 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 75 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)

TABLE 76 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 77 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 78 JAPAN GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 79 JAPAN INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 80 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 81 JAPAN GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 82 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 83 CHINA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 84 CHINA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 85 CHINA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 86 CHINA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 87 CHINA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 88 CHINA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 89 CHINA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 90 CHINA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 91 CHINA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)

TABLE 92 CHINA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 93 CHINA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 94 CHINA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 95 CHINA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 96 CHINA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 97 CHINA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 98 CHINA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 99 INDIA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 100 INDIA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 101 INDIA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 102 INDIA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 103 INDIA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 104 INDIA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 105 INDIA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 106 INDIA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 107 INDIA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)

TABLE 108 INDIA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 109 INDIA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 110 INDIA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 111 INDIA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 112 INDIA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 113 INDIA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 114 INDIA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 115 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 116 SOUTH KOREA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 117 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 118 SOUTH KOREA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 119 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 120 SOUTH KOREA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 121 SOUTH KOREA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 122 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 123 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)

TABLE 124 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 125 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 126 SOUTH KOREA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 127 SOUTH KOREA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 128 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 129 SOUTH KOREA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 130 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 131 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 132 AUSTRALIA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 133 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 134 AUSTRALIA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 135 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 136 AUSTRALIA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 137 AUSTRALIA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 138 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 139 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)

TABLE 140 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 141 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 142 AUSTRALIA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 143 AUSTRALIA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 144 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 145 AUSTRALIA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 146 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 147 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 148 SINGAPORE PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 149 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 150 SINGAPORE CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 151 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 152 SINGAPORE RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 153 SINGAPORE ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 154 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 155 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)

TABLE 156 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 157 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 158 SINGAPORE GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 159 SINGAPORE INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 160 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 161 SINGAPORE GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 162 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 163 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 164 MALAYSIA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 165 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 166 MALAYSIA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 167 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 168 MALAYSIA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 169 MALAYSIA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 170 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 171 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)

TABLE 172 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 173 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 174 MALAYSIA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 175 MALAYSIA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 176 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 177 MALAYSIA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 178 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 179 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 180 THAILAND PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 181 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 182 THAILAND CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 183 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 184 THAILAND RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 185 THAILAND ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 186 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 187 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)

TABLE 188 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 189 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 190 THAILAND GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 191 THAILAND INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 192 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 193 THAILAND GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 194 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 195 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 196 INDONESIA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 197 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 198 INDONESIA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 199 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 200 INDONESIA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 201 INDONESIA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 202 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 203 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)

TABLE 204 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 205 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 206 INDONESIA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 207 INDONESIA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 208 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 209 INDONESIA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 210 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 211 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 212 PHILIPPINES PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

TABLE 213 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 214 PHILIPPINES CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)

TABLE 215 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 216 PHILIPPINES RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 217 PHILIPPINES ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 218 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 219 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)

TABLE 220 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 221 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 222 PHILIPPINES GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 223 PHILIPPINES INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 224 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 225 PHILIPPINES GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 226 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 227 REST OF ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)

 

図表一覧

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: MULTIVARIATE MODELLING

FIGURE 7 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: SEGMENTATION

FIGURE 12 AVAILABILITY OF DIVERSE RANGE OF INNOVATIVE SOLUTIONS FOR VECTOR PURIFICATION IS DRIVING THE ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET

FIGURE 15 ESTIMATED NUMBER OF NEW CASES IN MALE AND FEMALE (ALL AGE GROUP) WORLDWIDE IN 2018

FIGURE 1 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, 2020

FIGURE 2 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, 2021-2028 (USD MILLION)

FIGURE 3 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, CAGR (2021-2028)

FIGURE 4 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE

FIGURE 5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, 2020

FIGURE 6 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, 2021-2028 (USD MILLION)

FIGURE 7 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, CAGR (2021-2028)

FIGURE 8 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, LIFELINE CURVE

FIGURE 9 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE, 2020

FIGURE 10 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE, 2021-2028 (USD MILLION)

FIGURE 11 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 12 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE, LIFELINE CURVE

FIGURE 13 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, 2020

FIGURE 14 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, 2021-2028 (USD MILLION)

FIGURE 15 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, CAGR (2021-2028)

FIGURE 16 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, LIFELINE CURVE

FIGURE 17 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, 2020

FIGURE 18 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, 2021-2028 (USD MILLION)

FIGURE 19 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, CAGR (2021-2028)

FIGURE 20 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, LIFELINE CURVE

FIGURE 21 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, 2020

FIGURE 22 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, 2021-2028 (USD MILLION)

FIGURE 23 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, CAGR (2021-2028)

FIGURE 24 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, LIFELINE CURVE

FIGURE 25 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, 2020

FIGURE 26 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, 2021-2028 (USD MILLION)

FIGURE 27 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, CAGR (2021-2028)

FIGURE 28 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, LIFELINE CURVE

FIGURE 29 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, 2020

FIGURE 30 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, 2021-2028 (USD MILLION)

FIGURE 31 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 32 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 33 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY END USER, 2020

FIGURE 34 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY END USER, 2021-2028 (USD MILLION)

FIGURE 35 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY END USER, CAGR (2021-2028)

FIGURE 36 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY END USER, LIFELINE CURVE

FIGURE 37 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: SNAPSHOT (2020)

FIGURE 38 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY COUNTRY (2020)

FIGURE 39 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY COUNTRY (2021 & 2028)

FIGURE 40 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY COUNTRY (2020 & 2028)

FIGURE 41 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE (2021-2028)

FIGURE 42 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: COMPANY SHARE 2020 (%)

 

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The Asia-Pacific Viral Vector Purification Market is projected to grow at a CAGR of 15.3% during the forecast period by 2028.
The future market value of the Asia-Pacific Viral Vector Purification Market is expected to reach USD 266.22 million by 2028.
The major players in the Asia-Pacific Viral Vector Purification Market Applied Biological Materials Inc., Creative Biolabs, Bio-Rad Laboratories, Inc., Sirion-Biotech GmbH, Merck KGaA, Batavia Biosciences B.V., Agilent Technologies, Inc., Addgene, etc.
The countries covered in the Asia-Pacific Viral Vector Purification Market are Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines and rest of Asia-Pacific.